• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » The Canadian Cancer Clinical Trials Network launches awareness campaign for cancer trials

The Canadian Cancer Clinical Trials Network launches awareness campaign for cancer trials

May 9, 2016
CenterWatch Staff

The Canadian Cancer Clinical Trials Network (3CTN) has announced the roll out of a new national campaign to raise awareness of cancer clinical trials in Canada ahead of International Clinical Trials Day on May 20.

The Ask Me Campaign will be introduced at more than 60 cancer centers across Canada and include hospital staff wearing "Ask Me" buttons, as well as posters and brochures placed in hospitals. These will be used to encourage patients to engage their healthcare team in a conversation about clinical trials and see if a trial may be a treatment option for them. The ultimate goal is to increase awareness about, and enrolment in, cancer clinical trials in Canada.

"We've seen a decline in enrollment in clinical trials in Canada, which is a trend that we are aiming to reverse," said Dr. Janet Dancey, scientific director of the 3CTN. "A big part of this is making sure the patients who are undergoing treatment for cancer are aware that world-class clinical trials are underway in their province, that they may be eligible to participate and that these trials may help them."

There are many positive aspects to cancer trials, both for patients and for society at large. Data show that patients treated in institutions with an active clinical trial program have improved outcomes. There also may be substantial drug cost savings for institutions, increased ability to recruit and retain world-class researchers and doctors and increased knowledge translation and innovation.

"The Ask Me Campaign is a great platform to raise awareness of clinical trials as we often hear from patients and families that they are not aware of the potential benefits of participating in a clinical trial," said Sujata Pokhrel, clinical research associate at the Royal Victoria Regional Health Centre. "By wearing the Ask Me about Clinical Trials button, we will promote a discussion about this potential treatment option between the patient, family members and their healthcare providers." 

A 2011 report by Canadian Cancer Research Alliance showed that clinical trials in Canada are under threat, with patient enrolment in clinical trials on the decline. If studies are under-enrolled they may close, which means the research question is never answered, the trial may move to another jurisdiction, and Canadian patients may lose access to potentially cutting-edge care. 3CTN was established in 2013 to address this problem and ensure Canada remains a world-leading jurisdiction for academic cancer trials.

3CTN is a not-for-profit, pan-Canadian initiative aimed at supporting and improving the efficient delivery of academic cancer clinical trials through funding, resources and advocacy to improve the clinical trial environment and increase patient access to cancer clinical trials.

One of 3CTN's main goals is increase patient recruitment to academically sponsored cancer clinical trials in 75 Network Centres. 3CTN has a number of ongoing initiatives to increase patient recruitment, one of which is the Ask Me Campaign. 

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing